Top banner. Identify the target take action. Image of lungs with 'BRAF V600+' text written on it. Accompanying text 'Efficacy of TAFINLAR (dabrafenib) + MEKINIST (trametinib)' written on the banner.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]